Expression of toll-like receptor 2 in glomerular endothelial cells and promotion of diabetic nephropathy by Porphyromonas gingivalis lipopolysaccharide

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Sawa, Yoshihiko ^a   Takata, Shunsuke ^a   Hatakeyama, Yuji ^a   Ishikawa, Hiroyuki ^a   Tsuruga, Eichi ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GLUCOSE; INTERLEUKIN 6; PORPHYROMONAS GINGIVALIS LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; LIPOPOLYSACCHARIDE; TLR2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS EPITHELIUM; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; LASER MICROSCOPY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PERIODONTITIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; ENDOTHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; METABOLISM; PORPHYROMONAS GINGIVALIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY;

ANALYSIS OF VARIANCE; ANIMALS; COLLAGEN TYPE I; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENDOTHELIAL CELLS; IN SITU HYBRIDIZATION; INTERLEUKIN-6; KIDNEY GLOMERULUS; LIPOPOLYSACCHARIDES; MICE; PORPHYROMONAS GINGIVALIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901311770     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097165     Document Type: Article

References (37)

1. Forbes JM, Cooper ME, Oldfield MD, Thomas MC (2003) Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 14: 254-258.
2. Yan SF, Ramasamy R, Schmidt AM (2008) Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 4: 285-293. (Pubitemid 351571138)
3. Antonetti DA, Klein R, Gardner TW (2012) Mechanisms of Disease: Diabetic Retinopathy. N Engl J Med 366: 1227-1239.
4. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, et al. (1984) Structural functional relationships in diabetic nephropathy. J Clin Invest 74: 1143-1155. (Pubitemid 15210185)
5. Steffes MW, Osterby R, Chavers B, Mauer SM (1987) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081.
6. Haneda M, Koya D, Isono M, Kikkawa R (2003) Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol 14: 1374-1382. (Pubitemid 36514677)
7. Mason RM, Wahab NA (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 1358-1373. (Pubitemid 36519197)
8. van Beijnum JR, Buurman WA, Griffioen AW (2008) Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11: 91-99.
9. Wong FS, Wen L (2008) Toll-like receptors and diabetes. Ann NY Acad Sci 1150: 123-132.
10. Dasu MR, Devaraj S, Park S, Jialal I (2010) Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33: 861-868.
11. Li C, Wang Y, Gao L, Zhang J, Shao J, et al. (2002) Expression of toll-like receptors 2 and 4 and CD14 during differentiation of HL-60 cells induced by phorbol 12-myristate 13-acetate and 1 alpha, 25-dihydroxy-vitamin D(3). Cell Growth Differ 13: 27-38. (Pubitemid 34106797)
12. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376. (Pubitemid 37174535)
13. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
14. Schaeffler A, Gross P, Buettner R, Bollheimer C, Buechler C, et al. (2009) Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126: 233-245.
15. Cheng A, Dong Y, Zhu F, Liu Y, Hou FF, et al. (2013) AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells. Int J Biol Sci 9: 94-107.
16. Zhou Q, Desta T, Fenton M, Graves DT, Amar S (2005) Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun 73: 935-943. (Pubitemid 40165752)
17. Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, et al. (2009) Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem 284: 23107-23115.
18. Lei L, Li H, Yan F, Xiao Y (2013) Hyperlipidemia impaired innate immune response to periodontal pathogen Porphyromonas gingivalis in apolipoprotein E knockout mice. PLoS One 8: e71849. Available: http://www.plosone.org/article/ info%3Adoi%2F10.1371%2Fjournal.pone.0071849. Accessed 16 August 2013.
19. Li F, Yang N, Zhang L, Tan H, Huang B, et al. (2010) Increased expression of toll-like receptor 2 in rat diabetic nephropathy. Am J Nephrol 32: 179-186.
20. Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, et al. (2012) Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 23: 86-102.
21. Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H, et al. (2013) The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 305: 143-154.
22. Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, et al. (2003) Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108: 2905-2910. (Pubitemid 37517819)
23. Sherry CL, O'Connor JC, Kramer JM, Freund GG (2007) Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. J Immunol 178: 663-670. (Pubitemid 46095138)
24. Eskan MA, Benakanakere MR, Rose BG, Zhang P, Zhao J, et al. (2008) Interleukin-1beta modulates proinflammatory cytokine production in human epithelial cells. Infect Immun 76: 2080-2089. (Pubitemid 351656141)
25. Takata S, Sawa Y, Uchiyama T, Ishikawa H (2013) Expression of toll-like receptor 4 in glomerular endothelial cells under diabetic conditions. Acta Histochem Cytochem 46: 35-42.
26. Fan MH, Wong KL, Wu S, Leung WK, Yam WC, et al. (2010) Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion. J Periodontal Res 45: 100-108.
27. Herminajeng E, Sosroseno W, Bird PS, Seymour GJ (2001) The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model. J Periodontol 72: 1527-1534. (Pubitemid 33130643)
28. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC (2008) Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 93: 578-583. (Pubitemid 351240834)
29. Devaraj S, Jialal I, Yun JM, Bremer A (2011) Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism 60: 256-259.
30. Devaraj S, Tobias P, Kasinath BS, Ramsamooj R, Afify A (2011) Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol 31: 1796-1804.
31. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, et al. (2012) Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Tolllike receptor 4 in mice. Diabetologia 55: 2256-2266.
32. Kato M, Zhang J, Wang M, Lanting L, Yuan H, et al. (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104: 3432-3437. (Pubitemid 46364176)
33. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332. (Pubitemid 350073596)
34. Kaur H, Chien A, Jialal I (2012) Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol 303: 1145-1150.
35. Cheng X, Gao W, Dang Y, Liu X, Li Y, et al. (2013) Both ERK/MAPK and TGF-beta/Smad signaling pathways play a role in the kidney fibrosis of diabetic mice accelerated by blood glucose fluctuation. J Diabetes Res 2013: 463740.
36. Hornigold N, Johnson TS, Huang L, Haylor JL, Griffin M, et al. (2013) Inhibition of collagen I accumulation reduces glomerulosclerosis by a Hic-5-dependent mechanism in experimental diabetic nephropathy. Lab Invest 93: 553-565.
37. Huang C, Shen S, Ma Q, Chen J, Gill A, et al. (2013) Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice. Diabetes 62: 2923-2934.